New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE… 06/16/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021
What Does $11M in Donations to Congress Buy Pharma? 08/12/2020
PRMA Consulting Announces New Singapore Office and Virtual Open House 08/11/2020